Yasir Furkan Cagin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yasir Furkan Cagin has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
Alaadin Polat
Inonu University, Faculty of Medicine, Department of Physiology, Malatya, Turkey
5 shared publicationsMehmet Ali Erdogan
Inonu University, Faculty of Medicine, Department of Gastroenterology, Malatya, Turkey
5 shared publications- Hakan Parlakpinar
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
4 shared publications Kevser Tanbek
Inonu Universitesi Tip fakultesi
4 shared publicationsNigar Vardi
Inonu Universitesi Tip fakultesi
4 shared publicationsYahya Atayan
4 shared publications
Latest Publications
- Open Access
- 30 January 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (4) , 526-528
Upadacitinib-Induced Sepsis Resulting in Death in Crohn’s Disease: The First Reported Case
Cite this article as: Keser MF, Atayan Y, Duru M, Çağın AH, Keser ZB, Çağın YF. Upadacitinib-induced sepsis resulting in death in crohn’s disease: The first reported case. Turk J Gastroenterol. Published online January 30, 2026. doi:10.5152/tjg.2026.25637.
- 30 January 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (4) , 526-528
Open AccessUpadacitinib-Induced Sepsis Resulting in Death in Crohn’s Disease: The First Reported Case
Cite this article as: Keser MF, Atayan Y, Duru M, Çağın AH, Keser ZB, Çağın YF. Upadacitinib-induced sepsis resulting in death in crohn’s disease: The first reported case. Turk J Gastroenterol. Published online January 30, 2026. doi:10.5152/tjg.2026.25637.
- Open Access
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 48-52
Efficiency of ledipasvir/sofosbuvir threatment in hepatitis C virus
Aims: This study analyzes the efficiency of a combination of ledipasvir/sofosbuvir (LED/SOF), a newly developed direct-acting antiviral agent, in patients infected with hepatitis C virus (HCV) with or without a treatment history [pegile-interferon±ribavirin (PEG-IFN±RBV)] who subsequently developed recurrence. Methods: Files of hepatitis C-infected patients who received LED/SOF treatment for 3-6 months with recurrence or without a treatment history (PEG-IFN±RBV) before admission to Gülhane Training and Research Hospital between 06.06.2016 and 23.05.2018 were taken into account. Results: This study included 45 patients, 20 of whom were female (44.4%) and 25 of whom were male (55.6%). Among those patients, 22 were administered PEG-IFN±RBV treatment and experienced recurrence, whereas 23 had no previous treatment history. Age; sex; 6-month aspartate aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin, and albumin, international normalized ratio (INR), hemoglobin (HGB) and thrombocyte (PLT) values; and 1-, 2- and 6-month-old HCV-RNA levels were evaluated in this study. When the pretreatment HCV-RNA levels and the 1st, 2nd and 6th month HCV-RNA levels were compared, the decrease in the values was statistically significant (p<0.05, p<0.05, p<0.05, p<0.05). The initial and 6-month AST, ALT, GGT, and ALB levels and the PLT were statistically significant (p<0.05, p<0.05, p<0.05, p<0.05, p<0.05, p<0.05, respectively). Conclusion: LED/SOF treatment in patients with or without HCV infection treatment experience was found to be reliable and successful.
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 48-52
Open AccessEfficiency of ledipasvir/sofosbuvir threatment in hepatitis C virus
Aims: This study analyzes the efficiency of a combination of ledipasvir/sofosbuvir (LED/SOF), a newly developed direct-acting antiviral agent, in patients infected with hepatitis C virus (HCV) with or without a treatment history [pegile-interferon±ribavirin (PEG-IFN±RBV)] who subsequently developed recurrence. Methods: Files of hepatitis C-infected patients who received LED/SOF treatment for 3-6 months with recurrence or without a treatment history (PEG-IFN±RBV) before admission to Gülhane Training and Research Hospital between 06.06.2016 and 23.05.2018 were taken into account. Results: This study included 45 patients, 20 of whom were female (44.4%) and 25 of whom were male (55.6%). Among those patients, 22 were administered PEG-IFN±RBV treatment and experienced recurrence, whereas 23 had no previous treatment history. Age; sex; 6-month aspartate aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin, and albumin, international normalized ratio (INR), hemoglobin (HGB) and thrombocyte (PLT) values; and 1-, 2- and 6-month-old HCV-RNA levels were evaluated in this study. When the pretreatment HCV-RNA levels and the 1st, 2nd and 6th month HCV-RNA levels were compared, the decrease in the values was statistically significant (p<0.05, p<0.05, p<0.05, p<0.05). The initial and 6-month AST, ALT, GGT, and ALB levels and the PLT were statistically significant (p<0.05, p<0.05, p<0.05, p<0.05, p<0.05, p<0.05, respectively). Conclusion: LED/SOF treatment in patients with or without HCV infection treatment experience was found to be reliable and successful.
- Open Access
- 23 June 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 36 (12) , 822-833
Three-Decade Analysis of Inflammatory Bowel Disease in Türkiye: A Multicenter Study (1993-2024)
Background/Aims: Inflammatory bowel diseases (IBDs) are increasingly prevalent and challenging globally. Data regarding IBD frequency and severity between Europe and Asia are needed. The aim was to investigate the trend of IBD in Türkiye during the last 3 decades. Materials and Methods: The study was conducted retrospectively at 14 centers in Türkiye between June 1993 and March 2024. Results: Over 30 years, 4308 patients, of whom 2507 (58.2%) had ulcerative colitis (UC) and 1717 (39.9%) had Crohn’s Disease (CD), were included in the study. The overall median age at the onset of IBD was 34.43 (25.28-45.64) years; the age at onset of IBD was younger in CD compared to UC (32.72 vs. 35.52 years respectively, P < .001). The peak age onset range was 28-32 years in CD, whereas 23-27 years in UC. Overall, 2526 (58.6%) patients were male. The most common location was left-sided colitis in UC patients (45.1%), followed by extensive colitis (31.2%), and proctitis (23.7%), while ileal involvement in CD patients (45.2%), afterward ileocolonic (409%), and colonic (13.5%). Both illnesses are becoming increasingly prevalent. The UC/CD ratio tends to decrease over time. During the study period, 1577 (36.6%) patients received biologic treatment. During the study period, 418 (24.3%) underwent resective surgery for CD and 88 (3.5%) total colectomy for UC; the major abdominal surgery has declined over time. Conclusion: The frequency and characteristic features of IBD in Türkiye appear to be between Europe and Asia. Over time, while the usage of biologic therapy and the rate of CD have increased, the frequency of surgery has decreased. Cite this article as: Durak MB, Cagin YF, Balkan A, et al. Three-decade analysis of inflammatory bowel disease in Türkiye: A multicenter study (1993-2024). Turk J Gastroenterol. 2025;36(12):822-833.
- 23 June 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 36 (12) , 822-833
Open AccessThree-Decade Analysis of Inflammatory Bowel Disease in Türkiye: A Multicenter Study (1993-2024)
Background/Aims: Inflammatory bowel diseases (IBDs) are increasingly prevalent and challenging globally. Data regarding IBD frequency and severity between Europe and Asia are needed. The aim was to investigate the trend of IBD in Türkiye during the last 3 decades. Materials and Methods: The study was conducted retrospectively at 14 centers in Türkiye between June 1993 and March 2024. Results: Over 30 years, 4308 patients, of whom 2507 (58.2%) had ulcerative colitis (UC) and 1717 (39.9%) had Crohn’s Disease (CD), were included in the study. The overall median age at the onset of IBD was 34.43 (25.28-45.64) years; the age at onset of IBD was younger in CD compared to UC (32.72 vs. 35.52 years respectively, P < .001). The peak age onset range was 28-32 years in CD, whereas 23-27 years in UC. Overall, 2526 (58.6%) patients were male. The most common location was left-sided colitis in UC patients (45.1%), followed by extensive colitis (31.2%), and proctitis (23.7%), while ileal involvement in CD patients (45.2%), afterward ileocolonic (409%), and colonic (13.5%). Both illnesses are becoming increasingly prevalent. The UC/CD ratio tends to decrease over time. During the study period, 1577 (36.6%) patients received biologic treatment. During the study period, 418 (24.3%) underwent resective surgery for CD and 88 (3.5%) total colectomy for UC; the major abdominal surgery has declined over time. Conclusion: The frequency and characteristic features of IBD in Türkiye appear to be between Europe and Asia. Over time, while the usage of biologic therapy and the rate of CD have increased, the frequency of surgery has decreased. Cite this article as: Durak MB, Cagin YF, Balkan A, et al. Three-decade analysis of inflammatory bowel disease in Türkiye: A multicenter study (1993-2024). Turk J Gastroenterol. 2025;36(12):822-833.
- 23 August 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
Evaluation of antioxidant prophylactic effects of parsley (Petroselinum crispum) on sepsis following cecal ligation and puncture
Sepsis causes release of free oxygen radicals that destroy membrane integrity.We evaluated the antioxidant effects of parsley, Petroselinum crispum(Pc), which has been used therapeutically for centuries in Anatolia, using a rat model of sepsis caused by cecal ligation and puncture (CLP).Wistar albino rats were separated into four groups of eight: a sham group with incised and sutured abdomen, a Pc extract(PcE) group was given 2 g/kg parsley extract for 14 days by gastric gavage, a CLP group with sepsis caused by CLP and a PcE + CLP group given parsley extract for 14 days, then made septic by CLP. PcE is given for 14 days and then sepsis is performed by the CLP procedure. The groups were compared in terms of hemogram, biochemical and histological characteristics. It has been proven that the administration of PcE before CLP-induced sepsis increases neutrophil, PLT counts and TAS levels which decrease with sepsis and decreases biochemical changes (BUN, AST, ALT, LDH, TOS, OSI) which increase with sepsis, to have a protective effect on sepsis . In the PcE + CLP group, the severity of intestinal infiltration was decreased significantly compared to the CLP group; epithelial damage was similar to the CLP group. In the PcE + CLP group, the crypt and villus length was greater and the decrease in Paneth cell degranulation intensity was found to be more than for the CLP group; also, the morphology of the cells was similar to the Sham group. PcE exhibit potential for prophylaxis for sepsis.
- 23 August 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
Evaluation of antioxidant prophylactic effects of parsley (Petroselinum crispum) on sepsis following cecal ligation and puncture
Sepsis causes release of free oxygen radicals that destroy membrane integrity.We evaluated the antioxidant effects of parsley, Petroselinum crispum(Pc), which has been used therapeutically for centuries in Anatolia, using a rat model of sepsis caused by cecal ligation and puncture (CLP).Wistar albino rats were separated into four groups of eight: a sham group with incised and sutured abdomen, a Pc extract(PcE) group was given 2 g/kg parsley extract for 14 days by gastric gavage, a CLP group with sepsis caused by CLP and a PcE + CLP group given parsley extract for 14 days, then made septic by CLP. PcE is given for 14 days and then sepsis is performed by the CLP procedure. The groups were compared in terms of hemogram, biochemical and histological characteristics. It has been proven that the administration of PcE before CLP-induced sepsis increases neutrophil, PLT counts and TAS levels which decrease with sepsis and decreases biochemical changes (BUN, AST, ALT, LDH, TOS, OSI) which increase with sepsis, to have a protective effect on sepsis . In the PcE + CLP group, the severity of intestinal infiltration was decreased significantly compared to the CLP group; epithelial damage was similar to the CLP group. In the PcE + CLP group, the crypt and villus length was greater and the decrease in Paneth cell degranulation intensity was found to be more than for the CLP group; also, the morphology of the cells was similar to the Sham group. PcE exhibit potential for prophylaxis for sepsis.
- Open Access
Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial
This study aimed to investigate the effects of the Mediterranean diet (MD), combined with curcumin and resveratrol supplementation, on disease activity, serum inflammatory markers, and quality of life in patients with mild-to-moderate active ulcerative colitis (UC). This study was designed as a prospective multicenter three-arm randomized controlled trial. Participants were randomized to the MD, MD + curcumin, and MD + resveratrol groups. All participants were placed on the MD for 8 weeks. The MD + curcumin group also received 1600 mg/day of curcumin supplementation, whereas the MD + resveratrol group received 500 mg/day of resveratrol supplementation for 8 weeks. Anthropometric measurements, Truelove–Witts Index, Short Form-36, Inflammatory Bowel Disease Questionnaire, Mediterranean Diet Adherence Scale (MEDAS), and laboratory tests were performed at baseline and postintervention. Within-group comparisons showed that MD, MD + curcumin, and MD + resveratrol interventions were effective in reducing disease activity and inflammation and improving quality of life in individuals with UC (p < 0.05). Between-group comparisons revealed no significant difference in all parameters except for the pain subparameter of SF-36 and the MEDAS score (p < 0.05). The MD is an effective and safe intervention to be used in clinical practice in individuals with UC.
Open AccessEffects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial
This study aimed to investigate the effects of the Mediterranean diet (MD), combined with curcumin and resveratrol supplementation, on disease activity, serum inflammatory markers, and quality of life in patients with mild-to-moderate active ulcerative colitis (UC). This study was designed as a prospective multicenter three-arm randomized controlled trial. Participants were randomized to the MD, MD + curcumin, and MD + resveratrol groups. All participants were placed on the MD for 8 weeks. The MD + curcumin group also received 1600 mg/day of curcumin supplementation, whereas the MD + resveratrol group received 500 mg/day of resveratrol supplementation for 8 weeks. Anthropometric measurements, Truelove–Witts Index, Short Form-36, Inflammatory Bowel Disease Questionnaire, Mediterranean Diet Adherence Scale (MEDAS), and laboratory tests were performed at baseline and postintervention. Within-group comparisons showed that MD, MD + curcumin, and MD + resveratrol interventions were effective in reducing disease activity and inflammation and improving quality of life in individuals with UC (p < 0.05). Between-group comparisons revealed no significant difference in all parameters except for the pain subparameter of SF-36 and the MEDAS score (p < 0.05). The MD is an effective and safe intervention to be used in clinical practice in individuals with UC.
- Open Access
- 7 March 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (1) , 33-38
The Course of Endoscopic Treatment Success in Biliary Complications After Living Donor Liver Transplantation
Our aim was to present the results of endoscopic retrograde cholangiopancreatography (ERCP) after living donor liver transplantation (LDLT) between February 2015 and June 2021. Clinical data included LDLT indications, time to perform ERCP after LDLT, number of ERCP procedures, indications for ERCP, and all treatment outcomes, including ERCP, percutaneous, and surgical interventions. We compared the obtained data with our previous study published by our team in 2018, which included 446 patients who underwent ERCP for biliary complications after LDLT between 2005 and 2015. We performed ERCP in 283 of 1506 patients with LDLT who underwent duct-to-duct anastomosis during transplantation and then developed biliary complications. Our endoscopic success rates were 60.9% and 71.0% in the previous and present studies, respectively. Our findings suggest that the success rate of endoscopic treatment of biliary complications in patients with LDLT increases in correlation with the increasing experience of clinicians treating these patients.
- 7 March 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (1) , 33-38
Open AccessThe Course of Endoscopic Treatment Success in Biliary Complications After Living Donor Liver Transplantation
Our aim was to present the results of endoscopic retrograde cholangiopancreatography (ERCP) after living donor liver transplantation (LDLT) between February 2015 and June 2021. Clinical data included LDLT indications, time to perform ERCP after LDLT, number of ERCP procedures, indications for ERCP, and all treatment outcomes, including ERCP, percutaneous, and surgical interventions. We compared the obtained data with our previous study published by our team in 2018, which included 446 patients who underwent ERCP for biliary complications after LDLT between 2005 and 2015. We performed ERCP in 283 of 1506 patients with LDLT who underwent duct-to-duct anastomosis during transplantation and then developed biliary complications. Our endoscopic success rates were 60.9% and 71.0% in the previous and present studies, respectively. Our findings suggest that the success rate of endoscopic treatment of biliary complications in patients with LDLT increases in correlation with the increasing experience of clinicians treating these patients.
- Open Access
- 20 July 2022
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 5 (4) , 1183-1189
Identification of lymphocyte subgroups with flow cytometry in COVID-19 patients
Objective: We aimed to determine lymphocyte subgroups and activation status of flow cytometry in COVID-19 patients and examine their relationship with disease stage and length of hospital stay. Material and Method: Forty patients were analyzed in this study and compared with the age and sex-matched 40 healthy controls. COVID-19 patients have split as early and advanced-stage diseases. Flow cytometry assay was performed to determine the counts of lymphocyte subsets and activation status. Total lymphocyte count was calculated and CD45 (cluster of differentiation), CD3, CD4, CD8, CD19, CD27, CD38, CD56, CD57, and IgD were studied on lymphocyte gate. T helper / T cytotoxic rates and length of hospital stay were recorded. Results: The patients' CD3(+)CD4(+) ( T helper) count and CD27 expression on T cells counts were significantly lower, and CD57 expression on CD3(+)CD8(+) T cytotoxic cells were significantly higher (p
- 20 July 2022
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 5 (4) , 1183-1189
Open AccessIdentification of lymphocyte subgroups with flow cytometry in COVID-19 patients
Objective: We aimed to determine lymphocyte subgroups and activation status of flow cytometry in COVID-19 patients and examine their relationship with disease stage and length of hospital stay. Material and Method: Forty patients were analyzed in this study and compared with the age and sex-matched 40 healthy controls. COVID-19 patients have split as early and advanced-stage diseases. Flow cytometry assay was performed to determine the counts of lymphocyte subsets and activation status. Total lymphocyte count was calculated and CD45 (cluster of differentiation), CD3, CD4, CD8, CD19, CD27, CD38, CD56, CD57, and IgD were studied on lymphocyte gate. T helper / T cytotoxic rates and length of hospital stay were recorded. Results: The patients' CD3(+)CD4(+) ( T helper) count and CD27 expression on T cells counts were significantly lower, and CD57 expression on CD3(+)CD8(+) T cytotoxic cells were significantly higher (p
- 1 January 2022
- Published by Kare Publishing in Diagnostic and Interventional Endoscopy
- Vol. 1 (3) , 58-61
Three-Year Follow-Up Findings of Colorectal Neoplastic Patients Who Underwent Endoscopic Submucosal Dissection: A Single-Center Experience
Objective: The removal of colorectal neoplastic lesions by endoscopic resection methods is recommended. These lesions could also be removed by endoscopic mucosal resection method. However, endoscopic mucosal resection is not ideal since it might leave residual neoplastic tissue and could not allow for a detailed histopathological evaluation. Most lesions could be removed by the endoscopic submucosal dissection method en bloc and it allows for adequate histological evaluation. In this study, we aimed to demonstrate whether endoscopic submucosal dissection is an ideal and safe method for the removal of colorectal neoplastic lesions. Methods: The consecutive endoscopic submucosal dissection series of 70 patients who underwent colorectal endoscopic submucosal dissection between January 2018 and March 2022 at Inonu University, Faculty of Medicine Gastroenterology Clinic were reviewed. Non-invasive early cancers larger than 10 mm with low lymph node metastasis risk and premalignant lesions larger than 15 mm were included in the study. Adenocarcinoma inclusion criteria were good histological differentiation, no ulceration at the lesion base, no submucosal invasion (assessed by endoscopic ultrasound), and no lymph node involvement identified in computed tomography or endoscopic ultrasound. Age, gender, endoscopic submucosal dissection indications, procedure duration, instruments used, complications, hospitalization duration, follow-up after discharge, pathological findings, and post-endoscopic submucosal dissection endoscopic findings were collected retrospectively. Results: All 70 cases who underwent endoscopic submucosal dissection were followed up by a single gastroenterologist for 36 months. Among the patients, 45 (64.2%) were female and 25 (35.8%) were male. Endoscopic submucosal dissection indications included intraepithelial lesions, high-grade dysplasia (n=30), low-grade dysplasia (n=16), neuroendocrine tumor (n=6), early-stage colorectal cancer (n=11), inflammatory polyp (n=2), and submucosal lesions [lipoma (n=2) and leiomyoma (n=3)]. The different types of lesions based on Paris classification are presented in Table 1. En bloc and piecemeal removal rates of the lesions with endoscopic submucosal dissection were 81.4% (57/70) and 18.6% (13/70), while pathologically complete and incomplete resection rates were 84.2% (59/70) and 15.8% (11/70), respectively. Perforation developed in 6 (8.5%) patients during the endoscopic submucosal dissection procedure. Three perforations developed in the rectum (2 Lateral Spreading Tumor [LST] and 1 early colonic cancer), 2 in the sigmoid colon (1 LST and 1 early colonic cancer), and 1 in the transverse colon (1 high-grade dysplasia). None of the colonic perforations required surgical intervention. All were closed with hemo-clips. Major bleeding was observed in 2 patients (2.8%). About 2 units of blood were transfused. Patients who developed major bleeding had early colon cancer and pseudodepressed LST. Minor bleeding (1 cecum, 2 transverse colons, 2 sigmoid colons, and 12 rectums) developed in 17 (24.3%) patients. Conclusion: In conclusion, as a center that just started to conduct advanced endoscopic procedures, our endoscopic submucosal dissection results were consistent with the literature. The analysis of the treatment, complications, and local recurrence pursuant to endoscopic submucosal dissection revealed satisfactory results when the endoscopic submucosal dissection was conducted with proper analysis of the lesions. All studies done on this topic, including this one, have shown good outcomes for the use of endoscopic submucosal dissection in suitable colorectal lesions, but there is a need to invest in more expertise and infrastructure to maximize the good outcomes of advanced endoscopic procedures
- 1 January 2022
- Published by Kare Publishing in Diagnostic and Interventional Endoscopy
- Vol. 1 (3) , 58-61
Three-Year Follow-Up Findings of Colorectal Neoplastic Patients Who Underwent Endoscopic Submucosal Dissection: A Single-Center Experience
Objective: The removal of colorectal neoplastic lesions by endoscopic resection methods is recommended. These lesions could also be removed by endoscopic mucosal resection method. However, endoscopic mucosal resection is not ideal since it might leave residual neoplastic tissue and could not allow for a detailed histopathological evaluation. Most lesions could be removed by the endoscopic submucosal dissection method en bloc and it allows for adequate histological evaluation. In this study, we aimed to demonstrate whether endoscopic submucosal dissection is an ideal and safe method for the removal of colorectal neoplastic lesions. Methods: The consecutive endoscopic submucosal dissection series of 70 patients who underwent colorectal endoscopic submucosal dissection between January 2018 and March 2022 at Inonu University, Faculty of Medicine Gastroenterology Clinic were reviewed. Non-invasive early cancers larger than 10 mm with low lymph node metastasis risk and premalignant lesions larger than 15 mm were included in the study. Adenocarcinoma inclusion criteria were good histological differentiation, no ulceration at the lesion base, no submucosal invasion (assessed by endoscopic ultrasound), and no lymph node involvement identified in computed tomography or endoscopic ultrasound. Age, gender, endoscopic submucosal dissection indications, procedure duration, instruments used, complications, hospitalization duration, follow-up after discharge, pathological findings, and post-endoscopic submucosal dissection endoscopic findings were collected retrospectively. Results: All 70 cases who underwent endoscopic submucosal dissection were followed up by a single gastroenterologist for 36 months. Among the patients, 45 (64.2%) were female and 25 (35.8%) were male. Endoscopic submucosal dissection indications included intraepithelial lesions, high-grade dysplasia (n=30), low-grade dysplasia (n=16), neuroendocrine tumor (n=6), early-stage colorectal cancer (n=11), inflammatory polyp (n=2), and submucosal lesions [lipoma (n=2) and leiomyoma (n=3)]. The different types of lesions based on Paris classification are presented in Table 1. En bloc and piecemeal removal rates of the lesions with endoscopic submucosal dissection were 81.4% (57/70) and 18.6% (13/70), while pathologically complete and incomplete resection rates were 84.2% (59/70) and 15.8% (11/70), respectively. Perforation developed in 6 (8.5%) patients during the endoscopic submucosal dissection procedure. Three perforations developed in the rectum (2 Lateral Spreading Tumor [LST] and 1 early colonic cancer), 2 in the sigmoid colon (1 LST and 1 early colonic cancer), and 1 in the transverse colon (1 high-grade dysplasia). None of the colonic perforations required surgical intervention. All were closed with hemo-clips. Major bleeding was observed in 2 patients (2.8%). About 2 units of blood were transfused. Patients who developed major bleeding had early colon cancer and pseudodepressed LST. Minor bleeding (1 cecum, 2 transverse colons, 2 sigmoid colons, and 12 rectums) developed in 17 (24.3%) patients. Conclusion: In conclusion, as a center that just started to conduct advanced endoscopic procedures, our endoscopic submucosal dissection results were consistent with the literature. The analysis of the treatment, complications, and local recurrence pursuant to endoscopic submucosal dissection revealed satisfactory results when the endoscopic submucosal dissection was conducted with proper analysis of the lesions. All studies done on this topic, including this one, have shown good outcomes for the use of endoscopic submucosal dissection in suitable colorectal lesions, but there is a need to invest in more expertise and infrastructure to maximize the good outcomes of advanced endoscopic procedures
- Open Access
- 22 November 2021
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 38 (6) , 348-356
Optimal Endoscopic Management of Anastomotic Strictures After Double- Biliary Reconstruction in Right Lobe Living-Donor Liver Transplantation
Background: There is no consensus on the optimal drainage technique in the management of biliary anastomotic strictures occurring after right-lobe living-donor liver transplantation (RL LDLT). Aims: To investigate whether there is a superiority between unilateral and bilateral drainage groups in terms of efficacy and safety of biliary drainage in RL LDLT patients undergoing double-biliary reconstruction. Study Design: Retrospective Cohort Methods: Between January 2009 and August 2019, 1693 patients underwent RL LDLT. Of these, 182 patients who developed biliary anastomotic strictures out of the 306 patients who had double-biliary reconstruction, were included in the study. One hundred fifty-five patients with technical success were divided into 2 groups as unilateral (n=116) and bilateral (n=39) drainage groups. The groups were compared in terms of variable parameters such as clinical success, additional procedure, post-ERCP complication, procedures after clinical failure, hospital stay, mortality, and survival. Results: The clinical success was higher in the bilateral group (70% vs. 82%, P =.201). In the initial and the follow-up periods, a total of 44 (38%) patients in the unilateral group were switched to the bilateral drainage group due to the increased need for stenting. The placement of a stent successfully solved the problem only in 28% (32/117) of the patients in the unilateral group, while this rate was 44% (17/39) in the bilateral group. The median follow-up time of both groups was 42 months, and was equal. The number of stent-free follow-up patients in the unilateral drainage group was less than that in the bilateral drainage group (4 and 7, respectively). Conclusion: An active attempt should be made for bilateral drainage in patients with biliary anastomotic stricture following RL LDLT. However, for patients in whom bilateral drainage is not possible, unilateral drainage may be recommended, with the placement of a maximum number of stents following primary biliary balloon dilatation, depending on the degree of stricture.
- 22 November 2021
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 38 (6) , 348-356
Open AccessOptimal Endoscopic Management of Anastomotic Strictures After Double- Biliary Reconstruction in Right Lobe Living-Donor Liver Transplantation
Background: There is no consensus on the optimal drainage technique in the management of biliary anastomotic strictures occurring after right-lobe living-donor liver transplantation (RL LDLT). Aims: To investigate whether there is a superiority between unilateral and bilateral drainage groups in terms of efficacy and safety of biliary drainage in RL LDLT patients undergoing double-biliary reconstruction. Study Design: Retrospective Cohort Methods: Between January 2009 and August 2019, 1693 patients underwent RL LDLT. Of these, 182 patients who developed biliary anastomotic strictures out of the 306 patients who had double-biliary reconstruction, were included in the study. One hundred fifty-five patients with technical success were divided into 2 groups as unilateral (n=116) and bilateral (n=39) drainage groups. The groups were compared in terms of variable parameters such as clinical success, additional procedure, post-ERCP complication, procedures after clinical failure, hospital stay, mortality, and survival. Results: The clinical success was higher in the bilateral group (70% vs. 82%, P =.201). In the initial and the follow-up periods, a total of 44 (38%) patients in the unilateral group were switched to the bilateral drainage group due to the increased need for stenting. The placement of a stent successfully solved the problem only in 28% (32/117) of the patients in the unilateral group, while this rate was 44% (17/39) in the bilateral group. The median follow-up time of both groups was 42 months, and was equal. The number of stent-free follow-up patients in the unilateral drainage group was less than that in the bilateral drainage group (4 and 7, respectively). Conclusion: An active attempt should be made for bilateral drainage in patients with biliary anastomotic stricture following RL LDLT. However, for patients in whom bilateral drainage is not possible, unilateral drainage may be recommended, with the placement of a maximum number of stents following primary biliary balloon dilatation, depending on the degree of stricture.
- 1 October 2021
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 60 (5) , 103250
Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis
- 1 October 2021
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 60 (5) , 103250
Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis